Rheumatoid Arthritis Clinical Trials

Showing 2921-2940 of 22,488 trials

SoftHand Comparison Study

NCT05328934

A trial to compare the performance of the SoftHand Pro (SHP) and Ossur i-Limb in people with transradial limb loss over an 8-week period.

Upper Extremity InjuryUpper Extremity Deformities, CongenitalAmputation, Traumatic+1 more

Mayo Clinic36 participantsStarted Apr 2022

Tempe, Arizona, United States • Rochester, Minnesota, United States

RECRUITINGPhase 1

Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

NCT05456243

This research study is being done to learn if an experimental treatment of infusing allogeneic adipose-derived mesenchymal stromal cells (allo-A-MSC ) directly into the renal artery is safe and can help reduce inflammation in the transplanted kidney and treat rejection.

Kidney Transplant

Mayo Clinic12 participantsStarted Jan 2023

Rochester, Minnesota, United States

RECRUITINGPhase 1

Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma

NCT05618925

Open-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combination With an IL-15 Superagonist (N-803) and Rituximab in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma. Up to 20 subjects will be enrolled and randomized 1:1 to 1 of 2 cohorts, as outlined below. The initial 3 subjects will be sequentially enrolled in a staggered fashion, with a 7 day interval between each subject to enable the capture and monitoring of any acute and subacute toxicities.

Non Hodgkin's Lymphoma Refractory/Relapsed

ImmunityBio, Inc.20 participantsStarted Aug 2025

Newport Beach, California, United States • Tyler, Texas, United States

SoftHand Comparison Study

Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma

Related Searches

Enhancing Memory in CPT for PTSD

Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer

Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

RELAXaHEAD for Headache Patients (Phase III)

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Imaging of Solid Tumors Using DLL3 SPECT

Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm